Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Premium: Strides Crash, Suven Disengages and It's a Sea of Portfolio Red

Strides Arcolab is down 10%. On the news that it has settled the Mylan outstanding (expected to be $250 million) for a final settlement of $150 million. Mylan bought the Agila division of Strides last year and had kept $250m pending as against potential issues with FDA on a plant that was issued a warning. It seems that has been reduced to $150 million. This is lower but we think it's . . .

Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial